These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27350629)

  • 21. CD3E as a new predictive biomarker of response to omalizumab treatment in asthma patients: Evidence from bioinformatic analysis.
    Zhang Q; Li H; Gao S; Wang J; Li C; Shu J; Lin J
    Int Immunopharmacol; 2021 Apr; 93():107423. PubMed ID: 33578181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers in the clinical development of asthma therapies.
    Staton TL; Choy DF; Arron JR
    Biomark Med; 2016; 10(2):165-76. PubMed ID: 26764286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of biomarkers to identify phenotypes and endotypes of severeasthma.
    Carr TF; Kraft M
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):414-420. PubMed ID: 30059792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice.
    Mahr TA; Malka J; Spahn JD
    Allergy Asthma Proc; 2013; 34(3):210-9. PubMed ID: 23462278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes.
    Haccuria A; Michils A; Michiels S; Van Muylem A
    J Allergy Clin Immunol; 2014 Sep; 134(3):554-9. PubMed ID: 24522091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches for identifying and testing potential new anti-asthma agents.
    Licari A; Castagnoli R; Brambilla I; Marseglia A; Tosca MA; Marseglia GL; Ciprandi G
    Expert Opin Drug Discov; 2018 Jan; 13(1):51-63. PubMed ID: 29077521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward clinically applicable biomarkers for asthma: An EAACI position paper.
    Diamant Z; Vijverberg S; Alving K; Bakirtas A; Bjermer L; Custovic A; Dahlen SE; Gaga M; Gerth van Wijk R; Giacco SD; Hamelmann E; Heaney LG; Heffler E; Kalayci Ö; Kostikas K; Lutter R; Olin AC; Sergejeva S; Simpson A; Sterk PJ; Tufvesson E; Agache I; Seys SF
    Allergy; 2019 Oct; 74(10):1835-1851. PubMed ID: 30953574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease.
    Kuruvilla ME; Lee FE; Lee GB
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):219-233. PubMed ID: 30206782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FeNO as biomarker for asthma phenotyping and management.
    Ricciardolo FL; Sorbello V; Ciprandi G
    Allergy Asthma Proc; 2015; 36(1):e1-8. PubMed ID: 25562547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological biomarkers in severe asthma.
    Narendra D; Blixt J; Hanania NA
    Semin Immunol; 2019 Dec; 46():101332. PubMed ID: 31735516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel biomarkers for asthma stratification and personalized therapy.
    Bartminski G; Crossley M; Turcanu V
    Expert Rev Mol Diagn; 2015 Mar; 15(3):415-30. PubMed ID: 25479456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway molecular endotypes of asthma: dissecting the heterogeneity.
    Wesolowska-Andersen A; Seibold MA
    Curr Opin Allergy Clin Immunol; 2015 Apr; 15(2):163-8. PubMed ID: 25961390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma: personalized and precision medicine.
    Canonica GW; Ferrando M; Baiardini I; Puggioni F; Racca F; Passalacqua G; Heffler E
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):51-58. PubMed ID: 29189350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target.
    Li W; Gao P; Zhi Y; Xu W; Wu Y; Yin J; Zhang J
    Respir Res; 2015 May; 16(1):57. PubMed ID: 25981515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sputum periostin in patients with different severe asthma phenotypes.
    Bobolea I; Barranco P; Del Pozo V; Romero D; Sanz V; López-Carrasco V; Canabal J; Villasante C; Quirce S
    Allergy; 2015 May; 70(5):540-6. PubMed ID: 25631525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy of asthma: regular treatment or on demand?
    Montuschi P; Pagliari G; Fuso L
    Ther Adv Respir Dis; 2009 Aug; 3(4):175-91. PubMed ID: 19671618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What goes up must come down: biomarkers and novel biologicals in severe asthma.
    Hilvering B; Pavord ID
    Clin Exp Allergy; 2015 Jul; 45(7):1162-9. PubMed ID: 25640208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of targeting interleukin 5 in asthma.
    Walsh GM
    BioDrugs; 2013 Dec; 27(6):559-63. PubMed ID: 23728885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Asthma in Primary Care: Identification and Management.
    Trevor JL; Chipps BE
    Am J Med; 2018 May; 131(5):484-491. PubMed ID: 29355509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.